136 related articles for article (PubMed ID: 18344634)
1. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients.
Ohashi N; Kato A; Misaki T; Sakakima M; Fujigaki Y; Yamamoto T; Hishida A
Intern Med; 2008; 47(6):485-91. PubMed ID: 18344634
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E; Waked E; Nabil M; El-Bendary O
Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
[TBL] [Abstract][Full Text] [Related]
3. Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients.
El-Shafey EM; Shalan M
Ther Apher Dial; 2014 Apr; 18(2):185-92. PubMed ID: 24720410
[TBL] [Abstract][Full Text] [Related]
4. Association of Adiponectin with High-Sensitivity C-Reactive Protein and Clinical Outcomes in Peritoneal Dialysis Patients: A 3.5-Year Follow-Up Study.
Tung CW; Hsu YC; Shih YH; Lin CL
PLoS One; 2015; 10(10):e0141058. PubMed ID: 26474473
[TBL] [Abstract][Full Text] [Related]
5. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients.
Odamaki M; Furuya R; Kinumura Y; Ikegaya N; Kumagai H
Nephron Clin Pract; 2006; 102(1):c8-13. PubMed ID: 16166803
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease.
Amira OC; Naicker S; Manga P; Sliwa K; Mia A; Raal F; Crowther NJ; Immelman RA; Olorunju S
Hemodial Int; 2012 Jan; 16(1):59-68. PubMed ID: 22099423
[TBL] [Abstract][Full Text] [Related]
7. Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients.
Spoto B; Mattace-Raso F; Sijbrands E; Pizzini P; Cutrupi S; D'Arrigo G; Tripepi G; Zoccali C; Mallamaci F
Nephrol Dial Transplant; 2013 Nov; 28 Suppl 4():iv181-7. PubMed ID: 23975745
[TBL] [Abstract][Full Text] [Related]
8. Plasma adiponectin levels and clinical outcomes among haemodialysis patients.
Rao M; Li L; Tighiouart H; Jaber BL; Pereira BJ; Balakrishnan VS;
Nephrol Dial Transplant; 2008 Aug; 23(8):2619-28. PubMed ID: 18334528
[TBL] [Abstract][Full Text] [Related]
9. [Analysis of metabolic syndrome and pulse wave velocity in hemodialysis patients: diagnosis of obesity by bioelectrical impedance analysis and a novel risk factor for atherosclerosis].
Sasaki N; Takeda S; Saito T; Ando Y; Kusano E
Nihon Jinzo Gakkai Shi; 2009; 51(4):476-83. PubMed ID: 19601557
[TBL] [Abstract][Full Text] [Related]
10. Relationship of high-molecular-weight adiponectin levels to visceral fat accumulation in hemodialysis patients.
Tamei N; Ogawa T; Ishida H; Ando Y; Nitta K
Intern Med; 2010; 49(4):299-305. PubMed ID: 20154435
[TBL] [Abstract][Full Text] [Related]
11. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.
Zoccali C; Mallamaci F; Tripepi G; Benedetto FA; Cutrupi S; Parlongo S; Malatino LS; Bonanno G; Seminara G; Rapisarda F; Fatuzzo P; Buemi M; Nicocia G; Tanaka S; Ouchi N; Kihara S; Funahashi T; Matsuzawa Y
J Am Soc Nephrol; 2002 Jan; 13(1):134-141. PubMed ID: 11752030
[TBL] [Abstract][Full Text] [Related]
12. Higher serum beta2-microglobulin levels are associated with better survival in chronic hemodialysis patients: a reverse epidemiology.
Kim KM; Kim SS; Kim H; Koo T; Im EY; Kim SB
Clin Nephrol; 2011 May; 75(5):458-65. PubMed ID: 21543026
[TBL] [Abstract][Full Text] [Related]
13. The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients.
Markaki A; Kyriazis J; Stylianou K; Fragkiadakis GA; Perakis K; Margioris AN; Ganotakis ES; Daphnis E
PLoS One; 2012; 7(12):e52350. PubMed ID: 23285003
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of baseline adiponectin on all-cause mortality in hemodialysis patients depending on initial body mass index. Long-term follow-up data of 4.5 years.
Tsigalou C; Chalikias G; Kantartzi K; Tziakas D; Kampouromiti G; Vargemezis V; Konstantinides S; Ktenidou-Kartali S; Simopoulos K; Passadakis P
J Ren Nutr; 2013 Jan; 23(1):45-56. PubMed ID: 22406123
[TBL] [Abstract][Full Text] [Related]
15. Serum adiponectin levels and mortality after kidney transplantation.
Alam A; Molnar MZ; Czira ME; Rudas A; Ujszaszi A; Kalantar-Zadeh K; Rosivall L; Mucsi I
Clin J Am Soc Nephrol; 2013 Mar; 8(3):460-7. PubMed ID: 23220424
[TBL] [Abstract][Full Text] [Related]
16. The Different Association between Serum Ferritin and Mortality in Hemodialysis and Peritoneal Dialysis Patients Using Japanese Nationwide Dialysis Registry.
Maruyama Y; Yokoyama K; Yokoo T; Shigematsu T; Iseki K; Tsubakihara Y
PLoS One; 2015; 10(11):e0143430. PubMed ID: 26599216
[TBL] [Abstract][Full Text] [Related]
17. Association of high-molecular-weight to total adiponectin ratio with pulse wave velocity in hemodialysis patients.
Kato A; Odamaki M; Ishida J; Hishida A
Nephron Clin Pract; 2008; 109(1):c18-24. PubMed ID: 18493156
[TBL] [Abstract][Full Text] [Related]
18. Serum adiponectin and protein-energy wasting in predialysis chronic kidney disease.
Hyun YY; Lee KB; Oh KH; Ahn C; Park SK; Chae DW; Yoo TH; Cho KH; Kim YS; Hwang YH;
Nutrition; 2017 Jan; 33():254-260. PubMed ID: 27692989
[TBL] [Abstract][Full Text] [Related]
19. Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status.
Norata GD; Baragetti I; Raselli S; Stucchi A; Garlaschelli K; Vettoretti S; Piloni G; Buccianti G; Catapano AL
Nutr Metab Cardiovasc Dis; 2010 Jan; 20(1):56-63. PubMed ID: 19359150
[TBL] [Abstract][Full Text] [Related]
20. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]